Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Effects of the herbicide dicamba on nontarget plants and pollinator visitation.

Bohnenblust EW, Vaudo AD, Egan JF, Mortensen DA, Tooker JF.

Environ Toxicol Chem. 2016 Jan;35(1):144-51. doi: 10.1002/etc.3169. Epub 2015 Nov 24.

PMID:
26184786
2.

Habitat availability is a more plausible explanation than insecticide acute toxicity for U.S. grassland bird species declines.

Hill JM, Egan JF, Stauffer GE, Diefenbach DR.

PLoS One. 2014 May 20;9(5):e98064. doi: 10.1371/journal.pone.0098064. eCollection 2014.

3.

A comparison of the herbicide tolerances of rare and common plants in an agricultural landscape.

Egan JF, Graham IM, Mortensen DA.

Environ Toxicol Chem. 2014 Mar;33(3):696-702. doi: 10.1002/etc.2491. Epub 2014 Jan 31.

PMID:
24488525
4.

Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing.

Benn P, Chapman AR, Erickson K, Defrancesco MS, Wilkins-Haug L, Egan JF, Schulkin J.

Prenat Diagn. 2014 Feb;34(2):145-52. doi: 10.1002/pd.4272. Epub 2013 Dec 16.

PMID:
24222397
5.

Short-term neonatal outcomes in diamniotic twin pregnancies delivered after 32 weeks and indications of late preterm deliveries.

Shamshirsaz AA, Ravangard SF, Ozhand A, Haeri S, Shamshirsaz AA, Hussain N, Spiel M, Ogunleye O, Billstrom R, Sadowski A, Turner G, Timms D, Egan JF, Campbell WA.

Am J Perinatol. 2014 May;31(5):365-72. doi: 10.1055/s-0033-1334458. Epub 2013 Oct 28.

PMID:
24166683
6.

Efficacy of the genetic sonogram in a stepwise sequential protocol for down syndrome screening.

Shamshirsaz AA, Ravangard SF, Turner G, Borgida A, Janicki MB, Campbell WA, Zelop C, Shamshirsaz AA, Spiel M, Prabulos AM, Feldman D, Rodis J, Ingardia CJ, Gurram P, Fuller K, Fang YM, Benn P, Egan JF.

J Ultrasound Med. 2013 Sep;32(9):1607-13. doi: 10.7863/ultra.32.9.1607.

PMID:
23980222
7.

Direct and indirect effects of the synthetic-auxin herbicide dicamba on two lepidopteran species.

Bohnenblust E, Egan JF, Mortensen D, Tooker J.

Environ Entomol. 2013 Jun;42(3):586-94. doi: 10.1603/EN13021.

PMID:
23726069
8.

Reported experiences with prenatal care: is there a difference in patient satisfaction based on racial and ethnic background?

Johnson AM, Nwana C, Egan JF, Dumont-Mathieu T.

Conn Med. 2012 Nov-Dec;76(10):581-4.

PMID:
23243758
9.

Fetal hydronephrosis as a predictor of neonatal urologic outcomes.

Shamshirsaz AA, Ravangard SF, Egan JF, Prabulos AM, Shamshirsaz AA, Ferrer FA, Makari JH, Leftwich HK, Herbst KW, Billstrom RA, Sadowski A, Gurram P, Campbell WA.

J Ultrasound Med. 2012 Jun;31(6):947-54.

PMID:
22644692
10.
11.

The ObGyn clerkship: are students denied the opportunity to provide patient care and what is the role of gender?

Jiang X, Altomare C, Egan JF, Tocco DB, Schnatz PF.

Conn Med. 2012 Apr;76(4):231-6.

PMID:
22611723
12.

Quantifying vapor drift of dicamba herbicides applied to soybean.

Egan JF, Mortensen DA.

Environ Toxicol Chem. 2012 May;31(5):1023-31. doi: 10.1002/etc.1778. Epub 2012 Mar 13.

PMID:
22362509
13.

A case report of human granulocytic anaplasmosis (ehrlichiosis) in pregnancy and a literature review of tick-borne diseases in the United States during pregnancy.

Qasba N, Shamshirsaz AA, Feder HM, Campbell WA, Egan JF, Shamshirsaz AA.

Obstet Gynecol Surv. 2011 Dec;66(12):788-96. doi: 10.1097/OGX.0b013e31823e0d0e. Review.

PMID:
22192463
14.

Characteristics of nulliparous women who would consider cesarean delivery on maternal request.

Schimpf MO, Tulikangas PK, O'Sullivan DM, LaSala CA, Jacob MC, Egan JF.

Conn Med. 2011 Apr;75(4):207-18.

PMID:
21560726
15.

Distortions of sex ratios at birth in the United States; evidence for prenatal gender selection.

Egan JF, Campbell WA, Chapman A, Shamshirsaz AA, Gurram P, Benn PA.

Prenat Diagn. 2011 Jun;31(6):560-5. doi: 10.1002/pd.2747. Epub 2011 Mar 27.

PMID:
21442626
16.

2,4-Dichlorophenoxyacetic acid (2,4-D)-resistant crops and the potential for evolution of 2,4-D-resistant weeds.

Egan JF, Maxwell BD, Mortensen DA, Ryan MR, Smith RG.

Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):E37; author reply E38. doi: 10.1073/pnas.1017414108. Epub 2011 Mar 3. No abstract available.

17.

Demographic differences in Down syndrome livebirths in the US from 1989 to 2006.

Egan JF, Smith K, Timms D, Bolnick JM, Campbell WA, Benn PA.

Prenat Diagn. 2011 Apr;31(4):389-94. doi: 10.1002/pd.2702. Epub 2011 Feb 7.

PMID:
21302335
18.

The role of second-trimester serum screening in the post-first-trimester screening era.

Shamshirsaz AA, Benn P, Egan JF.

Clin Lab Med. 2010 Sep;30(3):667-76. doi: 10.1016/j.cll.2010.04.013. Review.

PMID:
20638580
19.

Determining a cutoff for fetal lung maturity with lamellar body count testing.

Janicki MB, Dries LM, Egan JF, Zelop CM.

J Matern Fetal Neonatal Med. 2009 May;22(5):419-22. doi: 10.1080/14767050902801710.

PMID:
19529999
20.

Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists.

Fang YM, Benn P, Campbell W, Bolnick J, Prabulos AM, Egan JF.

Am J Obstet Gynecol. 2009 Jul;201(1):97.e1-5. doi: 10.1016/j.ajog.2009.02.029. Epub 2009 May 21.

PMID:
19467637
21.

Perinatal and neonatal outcomes of triplet gestations based on placental chorionicity.

Spencer JV, Ingardia CJ, Nold CJ, Borgida AF, Herson VC, Egan JF.

Am J Perinatol. 2009 Sep;26(8):587-90. doi: 10.1055/s-0029-1220776. Epub 2009 Apr 15.

PMID:
19370511
22.

A comparison of reasons for choosing obstetrician/gynecologist subspecialty training.

Fang YM, Egan JF, Rombro T, Morris B, Zelop CM.

Conn Med. 2009 Mar;73(3):165-70.

PMID:
19353991
23.

Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.

Fang YM, MacKeen D, Egan JF, Zelop CM.

J Matern Fetal Neonatal Med. 2009 Mar;22(3):249-53. doi: 10.1080/14767050802638170.

PMID:
19330710
24.

Effects of genetic perturbation on seasonal life history plasticity.

Wilczek AM, Roe JL, Knapp MC, Cooper MD, Lopez-Gallego C, Martin LJ, Muir CD, Sim S, Walker A, Anderson J, Egan JF, Moyers BT, Petipas R, Giakountis A, Charbit E, Coupland G, Welch SM, Schmitt J.

Science. 2009 Feb 13;323(5916):930-4. doi: 10.1126/science.1165826. Epub 2009 Jan 15. Erratum in: Science. 2012 Apr 20;336(6079):296.

25.

Use of the genetic sonogram in the United States in 2001 and 2007.

Fang YM, Benn P, Egan JF.

J Ultrasound Med. 2008 Nov;27(11):1543-8.

PMID:
18946092
26.

Prevalence of the human papillomavirus in an inner-city indigent population with previously normal Pap tests.

Werden J, Schnatz PF, Mandavilli S, Allen G, Murphy JL, Greene JF, Egan JF, Sorosky JI.

J Low Genit Tract Dis. 2008 Oct;12(4):287-92. doi: 10.1097/LGT.0b013e31817e307b.

PMID:
18820543
27.
28.

Stepwise sequential screening for fetal aneuploidy.

Benn PA, Campbell WA, Zelop CM, Ingardia C, Egan JF.

Am J Obstet Gynecol. 2007 Sep;197(3):312.e1-5.

PMID:
17826434
29.

Second trimester prenatal ultrasound and screening for Down syndrome.

Benn PA, Egan JF.

Prenat Diagn. 2007 Sep;27(9):884. No abstract available.

PMID:
17724762
30.

The relationship between utilization of prenatal care and Down syndrome live births.

Morris BA, Egan JF, Fang YM, Campbell WA.

J Matern Fetal Neonatal Med. 2007 Apr;20(4):307-11.

PMID:
17437238
31.

Absent or shortened nasal bone length and the detection of Down Syndrome in second-trimester fetuses.

Gianferrari EA, Benn PA, Dries L, Brault K, Egan JF, Zelop CM.

Obstet Gynecol. 2007 Feb;109(2 Pt 1):371-5.

PMID:
17267838
32.

Reproducibility of risk figures in 2nd-trimester maternal serum screening for down syndrome: comparison of 2 laboratories.

Benn PA, Makowski GS, Egan JF, Wright D.

Clin Chem. 2006 Nov;52(11):2087-94. Epub 2006 Sep 21.

33.

The influence of body mass index on pregnancy outcomes.

Fiala JE, Egan JF, Lashgari M.

Conn Med. 2006 Jan;70(1):21-3.

PMID:
16479872
34.

Variation of fetal nasal bone length in second-trimester fetuses according to race and ethnicity.

Zelop CM, Milewski E, Brault K, Benn P, Borgida AF, Egan JF.

J Ultrasound Med. 2005 Nov;24(11):1487-9.

PMID:
16239650
35.

Frequency of echogenic intracardiac focus by race/ethnicity in euploid fetuses.

Borgida AF, Maffeo C, Gianferarri EA, Bolnick AD, Zelop CM, Egan JF.

J Matern Fetal Neonatal Med. 2005 Jul;18(1):65-6.

PMID:
16105794
36.

Trends in the use of second trimester maternal serum screening from 1991 to 2003.

Benn PA, Fang M, Egan JF.

Genet Med. 2005 May-Jun;7(5):328-31.

PMID:
15915084
37.

Use of the mitral valve-tricuspid valve distance as a marker of fetal endocardial cushion defects.

Bolnick AD, Zelop CM, Milewski B, Gianferrari EA, Borgida AF, Egan JF.

Am J Obstet Gynecol. 2004 Oct;191(4):1483-5.

PMID:
15507987
38.

Down syndrome births in the United States from 1989 to 2001.

Egan JF, Benn PA, Zelop CM, Bolnick A, Gianferrari E, Borgida AF.

Am J Obstet Gynecol. 2004 Sep;191(3):1044-8.

PMID:
15467587
39.
40.

Influence of gestational age and fetal heart rate on the fetal mechanical PR interval.

Bolnick AD, Borgida AF, Egan JF, Zelop CM.

J Matern Fetal Neonatal Med. 2004 May;15(5):303-5.

PMID:
15280120
41.

Changes in the utilization of prenatal diagnosis.

Benn PA, Egan JF, Fang M, Smith-Bindman R.

Obstet Gynecol. 2004 Jun;103(6):1255-60.

PMID:
15172861
42.

Multiple gestations: the importance of ultrasound.

Egan JF, Borgida AF.

Obstet Gynecol Clin North Am. 2004 Mar;31(1):141-58. Review.

PMID:
15062451
43.

Combined sonographic and biochemical markers for Down syndrome screening.

Pinette MG, Egan JF, Wax JR, Blackstone J, Cartin A, Benn PA.

J Ultrasound Med. 2003 Nov;22(11):1185-90.

PMID:
14620889
44.

The genetic sonogram in second trimester down syndrome screening.

Egan JF.

Clin Obstet Gynecol. 2003 Dec;46(4):897-908. Review. No abstract available.

PMID:
14595233
45.

Down syndrome screening using race-specific femur length.

Borgida AF, Zelop C, Deroche M, Bolnick A, Egan JF.

Am J Obstet Gynecol. 2003 Oct;189(4):977-9.

PMID:
14586338
46.

Mild pyelectasis: evaluating the relationship between gestational age and renal pelvic anterior-posterior diameter.

Odibo AO, Marchiano D, Quinones JN, Riesch D, Egan JF, Macones GA.

Prenat Diagn. 2003 Oct;23(10):824-7.

PMID:
14558027
47.

Variation of fetal humeral length in second-trimester fetuses according to race and ethnicity.

Zelop CM, Borgida AF, Egan JF.

J Ultrasound Med. 2003 Jul;22(7):691-3.

PMID:
12862267
48.

Cost analysis of Down syndrome screening in advanced maternal age.

Hartnett J, Borgida AF, Benn PA, Feldman DM, DeRoche ME, Egan JF.

J Matern Fetal Neonatal Med. 2003 Feb;13(2):80-4.

PMID:
12735407
49.

Incorporation of inhibin-A in second-trimester screening for Down syndrome.

Benn PA, Fang M, Egan JF, Horne D, Collins R.

Obstet Gynecol. 2003 Mar;101(3):451-4.

PMID:
12636947
50.

Combined second-trimester biochemical and ultrasound screening for Down syndrome.

Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF.

Obstet Gynecol. 2002 Dec;100(6):1168-76.

PMID:
12468159

Supplemental Content

Support Center